The Recombinant Amyloid-β Peptide Aβ1–42 Aggregates Faster and Is More Neurotoxic than Synthetic Aβ1–42
- 21 December 2009
- journal article
- research article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 396 (1), 9-18
- https://doi.org/10.1016/j.jmb.2009.12.016
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A facile method for expression and purification of the Alzheimer’s disease‐associated amyloid β‐peptideThe FEBS Journal, 2009
- Recombinant amyloid beta-peptide production by coexpression with an affibody ligandBMC Biotechnology, 2008
- The Ratio of Monomeric to Aggregated Forms of Aβ40 and Aβ42 Is an Important Determinant of Amyloid-β Aggregation, Fibrillogenesis, and ToxicityJournal of Biological Chemistry, 2008
- The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseasesThe EMBO Journal, 2008
- Aβ40 Protects Non-toxic Aβ42 Monomer from AggregationJournal of Molecular Biology, 2007
- 3D structure of Alzheimer's amyloid-β(1–42) fibrilsProceedings of the National Academy of Sciences, 2005
- Structure of β-amyloid fibrils and its relevance to their neurotoxicity: Implications for the pathogenesis of Alzheimer’s diseaseJournal of Bioscience and Bioengineering, 2005
- Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid FibrilsScience, 2005
- Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseasesNature Cell Biology, 2004
- The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formationNature Neuroscience, 2001